Publications

QUADRA: A Phase Ii, Open-Label, Single-Arm Study to Evaluate Niraparib in Patients (Pts) with Relapsed Ovarian Cancer (Roc) in 4Th or Later Line of Therapy: Results from the Tbrcamut Subset

AuthID
P-00V-TA3

Author(s)

Moore, K

Secord, A

Geller, M

Miller, D

Cloven, N

Fleming, G

Wahner Hendrickson, A

Azodi, M

DiSilvestro, P

Oza, A

Cristea, M

Berek, J

Chan, J

Rimel, B

Li, Y

Luptakova, K

Clark, R

Matulonis, U

Monk, B

Document Type

Article

Year published

2018

Published

in Annals of Oncology, ISSN: 0923-7534

Volume: 29, Pages: viii337

Indexing

Crossref^®4

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/annonc/mdy285.152

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

QUADRA: A Phase Ii, Open-Label, Single-Arm Study to Evaluate Niraparib in Patients (Pts) with Relapsed Ovarian Cancer (Roc) in 4Th or Later Line of Therapy: Results from the Tbrcamut Subset

Useful Links

Get Help

Federated Authentication (Click on the image)

QUADRA: A Phase Ii, Open-Label, Single-Arm Study to Evaluate Niraparib in Patients (Pts) with Relapsed Ovarian Cancer (Roc) in 4Th or Later Line of Therapy: Results from the Tbrcamut Subset

Useful Links

Get Help